Overview

* HCA Q3 revenue grows 9.6% to $19.161 bln, beating analyst expectations

* Net income for Q3 rises 29.4% to $1.643 bln

* Company raises 2025 guidance for revenue, net income, and adjusted EBITDA

Outlook

* HCA Healthcare ( HCA ) raises 2025 revenue guidance to $75 bln-$76.5 bln

* Company increases 2025 net income forecast to $6.495 bln-$6.715 bln

* HCA Healthcare ( HCA ) expects 2025 EPS of $27.00-$28.00 per diluted share

Result Drivers

* ADMISSIONS GROWTH - Same facility admissions increased 2.1%, contributing to revenue growth

* REVENUE PER ADMISSION - Same facility revenue per equivalent admission increased 6.6%, boosting overall revenue

* WEATHER IMPACT - Absence of hurricane-related disruptions in 2025 compared to 2024 supported results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $19.16 $18.56

Revenue bln bln (18

Analysts

)

Q3 $6.96

ADJUSTED

EPS

Q3 EPS $6.96

Q3 Net $1.90

Income bln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for HCA Healthcare Inc ( HCA ) is $430.00, about 2.4% below its October 23 closing price of $440.16

* The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)